L1CAM-ECD stimulated the activation of ERK, FAK and Src and provided resistance against apoptosis [16,33,76] and increased L1CAM-ECD in ovarian cancer patients correlates with increased chemoresistance [34]. Here, PTK2 is linked to ovarian cancer.